Roshan covers India's startup and VC ecosystem from Bengaluru. Formerly at Reuters, he focused on equity markets, Wall Street insights, commodities, and led COVID data efforts. Outside work, he enjoys music, playing the keyboard, and watching movies and TV series.
Healthcare
Bottomline: PE-controlled Maiva Pharma faces headwinds amid project delays
Sterile injectables manufacturer Maiva Pharma Pvt Ltd, jointly controlled by Morgan Stanley Private Equity Asia and ......
People
Pantheon, Bain Capital, pi Ventures see senior-level people moves
US private equity major Bain Capital has strengthened its senior management with a new hire, while Indian deep-tech ......
Healthcare
Healthcare RCM firm ACN raises private capital
Mumbai-based ACN Healthcare, which offers healthcare revenue cycle management (RCM) services and has operations in India......
General
Deals Digest: PE-VC activity jumps; consumer, nutrition brands in key M&As
Private equity and venture capital dealmaking gathered steam for the second straight week while consumer and nutrition ......
Consumer
Fireside Ventures harvests dream returns as Wellbeing Nutrition finds a buyer
Consumer-focused venture capital firm Fireside Ventures is scoring sky-high returns on its investment in the ......
Healthcare
W Health Ventures marks first close of second fund, eyes final close soon
Healthcare-focused venture capital firm W Health Ventures has marked the first close of its second fund, months after ......
Finance
ValueQuest hits halfway mark for second flagship PE fund, sets final close timeline
ValueQuest Group, the public markets investor that entered the alternative investment space in 2023 with its debut ......
Healthcare
Toothsi parent makeO to acquire Peak XV-backed dental care firm Zenyum
Dental and skincare company makeO, backed by Eight Roads Ventures and 360 ONE Asset, has struck its second acquisition ......
Finance
Samara scores weak exit from services firm, wraps up second fund with robust returns
Mid-market private equity firm Samara Capital has exited a company it backed nine years ago with poor annualised returns......
Healthcare
Biotech startup Pandorum bags $18 mn to develop therapies for rare ocular diseases
Biotechnology firm Pandorum Technologies has raised $18 million (Rs 163 crore) in a Series B round to advance the ......